Compensation by vaccine
Influenza accounts for the largest share of VICP filings — about 71% of all cases on record. The bar chart below shows filings per vaccine, segmented by case outcome. Compensation rates vary widely by vaccine — flu shots have the highest compensation rate because SIRVA was added to the Vaccine Injury Table in 2017 and now qualifies for the Table presumption (no causation analysis needed). Vaccines without a Table claim require the petitioner to prove causation under Althen.
Click any vaccine name to view all cases for that vaccine.
Influenza accounts for the majority of VICP filings because SIRVA — shoulder injury related to vaccine administration — was added to the Vaccine Injury Table in 2017. Once an injury is on the Table, the petitioner doesn't have to prove the vaccine caused the injury; they just have to show the injury fits the Table criteria within the prescribed onset window. That's why flu-shot SIRVA cases compensate at >80% while autism-spectrum claims (off-Table, requiring full Althen causation analysis) compensate at <5%.
Detailed breakdown
| Vaccine | Total | Compensated | Rate | Median award | Total paid |
|---|---|---|---|---|---|
| Influenza | 8,546 | 7,208 | 84% | $81K | $884.0M |
| Tdap | 1,269 | 1,053 | 83% | $75K | $127.9M |
| HPV | 412 | 144 | 35% | $63K | $22.9M |
| Pneumococcal | 306 | 196 | 64% | $68K | $26.5M |
| MMR | 291 | 130 | 45% | $100K | $33.7M |
| DTaP | 286 | 119 | 42% | $120K | $46.1M |
| Hepatitis B | 258 | 131 | 51% | $70K | $28.8M |
| Hepatitis A | 130 | 89 | 68% | $100K | $16.0M |
| Rotavirus | 116 | 61 | 53% | $54K | $11.1M |
| Meningococcal | 114 | 77 | 68% | $70K | $10.8M |
| IPV/Polio | 112 | 41 | 37% | $137K | $17.1M |
| Hib | 100 | 36 | 36% | $108K | $19.2M |
| Varicella | 86 | 44 | 51% | $75K | $12.2M |
| COVID-19 | 22 | 10 | 45% | $53K | $486K |
| MMRV | 19 | 9 | 47% | $110K | $1.5M |
| Shingles | 9 | 2 | 22% | $125K | $195K |
Frequently asked questions about the VICP
General questions about the U.S. Vaccine Injury Compensation Program.